Neila Smith

1.1k total citations
37 papers, 806 citations indexed

About

Neila Smith is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Gastroenterology. According to data from OpenAlex, Neila Smith has authored 37 papers receiving a total of 806 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Surgery, 17 papers in Pulmonary and Respiratory Medicine and 11 papers in Gastroenterology. Recurrent topics in Neila Smith's work include Gastroesophageal reflux and treatments (11 papers), Electrolyte and hormonal disorders (11 papers) and Helicobacter pylori-related gastroenterology studies (9 papers). Neila Smith is often cited by papers focused on Gastroesophageal reflux and treatments (11 papers), Electrolyte and hormonal disorders (11 papers) and Helicobacter pylori-related gastroenterology studies (9 papers). Neila Smith collaborates with scholars based in United States, France and Japan. Neila Smith's co-authors include Joseph G. Verbalis, David Zeltser, Steven J. Rosansky, Guy Decaux, Djillali Annane, Eckhard Leifke, Jalal K. Ghali, Walker Long, James R. Taylor and Michael J. Koren and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Neila Smith

34 papers receiving 782 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Neila Smith United States 15 473 375 198 132 123 37 806
J.M. Gaya Spain 13 188 0.4× 264 0.7× 88 0.4× 5 0.0× 77 0.6× 45 648
Immacolata Esposito Italy 9 56 0.1× 99 0.3× 170 0.9× 73 0.6× 12 0.1× 37 634
Elizabeth Rock United States 9 225 0.5× 316 0.8× 17 0.1× 237 1.8× 8 0.1× 9 673
Albert Fung United States 13 108 0.2× 587 1.6× 534 2.7× 20 0.2× 7 0.1× 16 1.4k
Joseph H. Clark United States 12 127 0.3× 106 0.3× 101 0.5× 23 0.2× 4 0.0× 26 499
Adib A. Moukarzel United States 9 151 0.3× 202 0.5× 96 0.5× 41 0.3× 1 0.0× 12 727
Parker Vanamee United States 14 175 0.4× 156 0.4× 73 0.4× 25 0.2× 3 0.0× 34 557
Qianqian Zhu China 14 58 0.1× 187 0.5× 84 0.4× 35 0.3× 1 0.0× 42 463
Jianzhong Di China 16 121 0.3× 405 1.1× 97 0.5× 16 0.1× 3 0.0× 33 652
Hikaru Aoki Japan 10 78 0.2× 96 0.3× 76 0.4× 2 0.0× 52 0.4× 47 435

Countries citing papers authored by Neila Smith

Since Specialization
Citations

This map shows the geographic impact of Neila Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neila Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neila Smith more than expected).

Fields of papers citing papers by Neila Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neila Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neila Smith. The network helps show where Neila Smith may publish in the future.

Co-authorship network of co-authors of Neila Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Neila Smith. A scholar is included among the top collaborators of Neila Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Neila Smith. Neila Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chey, William D., Françis Mégraud, Loren Laine, et al.. (2024). Influence of patient characteristics on Helicobacter pylori eradication with Vonoprazan: A subgroup analysis of the pHalcon‐HP trial. JGH Open. 8(11). e70044–e70044. 1 indexed citations
2.
Laine, Loren, Stuart J. Spechler, Rena Yadlapati, et al.. (2024). Vonoprazan is Efficacious for Treatment of Heartburn in Non-erosive Reflux Disease: A Randomized Trial. Clinical Gastroenterology and Hepatology. 22(11). 2211–2220.e10. 12 indexed citations
3.
Howden, Colin W., Philip O. Katz, Kenneth R. DeVault, et al.. (2024). Integrated Analysis of Vonoprazan Safety for Symptomatic Gastro‐Oesophageal Reflux Disease or Erosive Oesophagitis. Alimentary Pharmacology & Therapeutics. 61(5). 835–851. 3 indexed citations
4.
Mulford, Darcy J., Diane Ramsden, Liming Zhang, et al.. (2023). Tiered approach to evaluate the CYP3A victim and perpetrator drug–drug interaction potential for vonoprazan using PBPK modeling and clinical data to inform labeling. CPT Pharmacometrics & Systems Pharmacology. 12(4). 532–544. 8 indexed citations
5.
Chey, William D., Françis Mégraud, Loren Laine, et al.. (2023). Sa1373 HELICOBACTER PYLORI ERADICATION RATES WITH VONOPRAZAN: SUBGROUP ANALYSIS FROM THE PHASE 3 PHALCON HP TRIAL. Gastroenterology. 164(6). S–378.
6.
Fass, Ronnie, Michael F. Vaezi, Prateek Sharma, et al.. (2023). Randomised clinical trial: Efficacy and safety of on‐demand vonoprazan versus placebo for non‐erosive reflux disease. Alimentary Pharmacology & Therapeutics. 58(10). 1016–1027. 21 indexed citations
7.
Fass, Ronnie, Michael F. Vaezi, Prateek Sharma, et al.. (2022). S390 Efficacy and Safety of On-Demand Vonoprazan versus Placebo in the Treatment of Heartburn in Symptomatic Nonerosive Reflux Disease (NERD) Patients: A Phase 2 Randomized Controlled Trial. The American Journal of Gastroenterology. 117(10S). e272–e273. 3 indexed citations
8.
Laine, Loren, Prateek Sharma, Darcy J. Mulford, et al.. (2022). Pharmacodynamics and Pharmacokinetics of the Potassium-Competitive Acid Blocker Vonoprazan and the Proton Pump Inhibitor Lansoprazole in US Subjects. The American Journal of Gastroenterology. 117(7). 1158–1161. 51 indexed citations
9.
Scarpignato, Carmelo, Eckhard Leifke, Neila Smith, et al.. (2021). A Population Pharmacokinetic Model of Vonoprazan: Evaluating the Effects of Race, Disease Status, and Other Covariates on Exposure. The Journal of Clinical Pharmacology. 62(6). 801–811. 18 indexed citations
10.
Marcinak, John, Melvin Munsaka, Paul B. Watkins, Takashi Ohira, & Neila Smith. (2018). Liver Safety of Fasiglifam (TAK-875) in Patients with Type 2 Diabetes: Review of the Global Clinical Trial Experience. Drug Safety. 41(6). 625–640. 33 indexed citations
11.
12.
Annane, Djillali, Guy Decaux, & Neila Smith. (2009). Efficacy and Safety of Oral Conivaptan, a Vasopressin-Receptor Antagonist, Evaluated in a Randomized, Controlled Trial in Patients With Euvolemic or Hypervolemic Hyponatremia. The American Journal of the Medical Sciences. 337(1). 28–36. 68 indexed citations
13.
14.
Smulders, Ronald, et al.. (2007). Pharmacokinetics, Safety, and Tolerability of Solifenacin in Patients With Renal Insufficiency. Journal of Pharmacological Sciences. 103(1). 67–74. 21 indexed citations
15.
Zeltser, David, et al.. (2007). Assessment of the Efficacy and Safety of Intravenous Conivaptan in Euvolemic and Hypervolemic Hyponatremia. American Journal of Nephrology. 27(5). 447–457. 151 indexed citations
16.
Lasseter, Kenneth C., Stacy C. Dilzer, & Neila Smith. (2007). Intravenous conivaptan: Effects on the QTc interval and other electrocardiographic parameters in healthy volunteers. Advances in Therapy. 24(2). 310–318. 2 indexed citations
17.
Swart, Pieter, Walter Krauwinkel, Ronald Smulders, & Neila Smith. (2006). Pharmacokinetic Effect of Ketoconazole on Solifenacin in Healthy Volunteers. Basic & Clinical Pharmacology & Toxicology. 99(1). 33–36. 21 indexed citations
18.
Ghali, Jalal K., Michael J. Koren, James R. Taylor, et al.. (2006). Efficacy and Safety of Oral Conivaptan: A V1A/V2Vasopressin Receptor Antagonist, Assessed in a Randomized, Placebo-Controlled Trial in Patients with Euvolemic or Hypervolemic Hyponatremia. The Journal of Clinical Endocrinology & Metabolism. 91(6). 2145–2152. 135 indexed citations
19.
Serels, Scott, et al.. (2006). MP-04.15. Urology. 68. 73–73. 5 indexed citations
20.
Smith, Neila. (1988). Everyday Aids and Appliances: Aids for urinary incontinence. BMJ. 296(6624). 772–773.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J.M. Gaya Breakdown of academic impact, for papers by Immacolata Esposito Breakdown of academic impact, for papers by Elizabeth Rock Breakdown of academic impact, for papers by Albert Fung Breakdown of academic impact, for papers by Joseph H. Clark Breakdown of academic impact, for papers by Adib A. Moukarzel Breakdown of academic impact, for papers by Parker Vanamee Breakdown of academic impact, for papers by Qianqian Zhu Breakdown of academic impact, for papers by Jianzhong Di Breakdown of academic impact, for papers by Hikaru Aoki
Rankless by CCL
2026